Passage Bio Inc. (PASG) NASDAQ

$1.53 0.03 (2.00%)

Market Cap: $81.83M

As of 02/07/23 03:05 PM EST. Market closed.

(PASG)

Passage Bio Inc. (PASG) NASDAQ

$1.53 0.03 (2.00%)

Market Cap: $81.83M

As of 02/07/23 03:05 PM EST. Market closed.

Passage Bio, has the mission to provide life-transforming gene therapies for patients with rare, monogenic CNS diseases that replace their suffering with boundless possibility, all while building lasting relationships with the communities it serves. Based in Philadelphia, PA, the company has established a strategic collaboration and licensing agreement with the renowned University of ... read more

Passage Bio, has the mission to provide life-transforming gene therapies for patients with rare, monogenic CNS diseases that replace their suffering with boundless possibility, all while building lasting relationships with the communities it serves. Based in Philadelphia, PA, the company has established a strategic collaboration and licensing agreement with the renowned University of Pennsylvania's Gene Therapy Program to conduct its discovery and IND-enabling preclinical work. This provides the team with enhanced access to a broad portfolio of gene therapy candidates and future gene therapy innovations that Passage Bio then pairs with its deep clinical, regulatory, manufacturing and commercial expertise to rapidly advance its robust pipeline of optimized gene therapies into clinical testing. As the company works with speed and tenacity, Passage Bio is always mindful of patients who may be able to benefit from its therapies. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Full Time Employees
133
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$1.49
Previous Close
$1.50
Days Range
$1.50 - $1.57
52 week range
$1.04 - $4.85
Volume
79,648
Avg. Volume (30 days)
108,526
Market Cap
$81.83M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
54,553,263
Open
$1.49
Previous Close
$1.50
Days Range
$1.50 - $1.57
52 week range
$1.04 - $4.85
Volume
79,648
Avg. Volume (30 days)
108,526
Market Cap
$81.83M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
54,553,263

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR PASSAGE BIO INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Kapadia SandipDirectorDec 01, 2022 Sale$1.195,0005,9640Dec 02, 2022, 05:14 PM
Fotopoulos AlexandrosChief Technical OfficerNov 22, 2022 Sale$1.333,7204,94820,245Nov 25, 2022, 04:15 PM
Toernsen Monika MariaChief Commercial OfficerSep 19, 2022 Sale$1.511,6812,5393,319Nov 18, 2022, 05:01 PM
ORBIMED ADVISORS LLC10% OwnerMay 04, 2022 Buy$1.94303,500588,7906,841,423May 05, 2022, 05:23 PM
ORBIMED ADVISORS LLC10% OwnerMay 03, 2022 Buy$1.93221,500427,4956,537,923May 05, 2022, 05:23 PM
ORBIMED ADVISORS LLC10% OwnerJan 20, 2022 Buy$5.0050,800254,0006,316,423May 05, 2022, 05:11 PM
Goldsmith Bruce ACEO and PresidentMar 21, 2022 Buy$3.1510,00031,50015,983Mar 23, 2022, 04:43 PM
ORBIMED ADVISORS LLC10% OwnerJan 20, 2022 Buy$5.42369,1002,000,5226,634,723Jan 24, 2022, 04:44 PM
ORBIMED ADVISORS LLC10% OwnerJan 19, 2022 Buy$5.1143,300221,2636,265,623Jan 20, 2022, 06:03 PM
ORBIMED ADVISORS LLC10% OwnerJan 18, 2022 Buy$5.46114,700626,2626,222,323Jan 20, 2022, 06:03 PM
ORBIMED ADVISORS LLC10% OwnerJan 14, 2022 Buy$5.6010,30057,6806,107,623Jan 20, 2022, 06:03 PM
ORBIMED ADVISORS LLC10% OwnerJan 12, 2022 Buy$5.65100,000565,0006,055,523Jan 13, 2022, 07:37 PM
ORBIMED ADVISORS LLC10% OwnerJan 11, 2022 Buy$5.538,20045,3465,955,523Jan 13, 2022, 07:37 PM
ORBIMED ADVISORS LLC10% OwnerJan 13, 2022 Buy$5.5241,800230,7366,097,323Jan 13, 2022, 07:37 PM
Quigley Jill M.Chief Operating OfficerDec 08, 2021 Option Exercise$0.2371,97516,554368,754Dec 10, 2021, 05:30 PM
Romano GaryChief Medical OfficerMar 15, 2021 Option Exercise$8.0710,00080,70010,000Mar 17, 2021, 09:12 PM
Romano GaryChief Medical OfficerMar 15, 2021 Sale$21.1010,000211,0131,617Mar 17, 2021, 09:12 PM
Quigley Jill M.Chief Operating OfficerJan 20, 2021 Sale$30.011,30039,011295,284Jan 22, 2021, 05:54 PM
Quigley Jill M.Chief Operating OfficerJan 14, 2021 Sale$30.1016,298490,570296,584Jan 15, 2021, 08:29 PM
Countouriotis AthenaDirectorMar 24, 2020 Buy$14.9810,000149,75018,900Mar 25, 2020, 08:26 PM
Ratcliffe LiamDirectorMar 03, 2020 Buy$18.002,80050,4002,800Mar 13, 2020, 05:20 PM
Ratcliffe LiamDirectorMar 03, 2020 Buy$18.00550,0009,900,0002,616,630Mar 13, 2020, 05:20 PM
ORBIMED ADVISORS LLC10% OwnerFeb 28, 2020 Buy$18.00373,3006,719,400373,300Mar 03, 2020, 07:07 PM
Versant Venture Capital VI, L.P.10% OwnerMar 03, 2020 Buy$18.00225,0004,050,000933,352Mar 03, 2020, 07:03 PM
Frazier Life Sciences IX, L.P.10% OwnerMar 03, 2020 Buy$18.00550,0009,900,0005,009,219Mar 03, 2020, 06:59 PM
Woiwode ThomasDirectorMar 03, 2020 Buy$18.00225,0004,050,000933,352Mar 03, 2020, 06:57 PM
Heron Patrick JDirectorMar 03, 2020 Buy$18.00550,0009,900,0005,009,219Mar 03, 2020, 06:54 PM
Yamada TadatakaDirectorMar 03, 2020 Buy$18.006,500117,000656,149Mar 03, 2020, 06:51 PM
Ratcliffe LiamDirectorMar 03, 2020 Buy$18.002,80050,4002,800Mar 03, 2020, 06:48 PM
Quigley Jill M.Chief Operating OfficerMar 03, 2020 Buy$18.001,00018,0001,000Mar 03, 2020, 06:46 PM
Quigley Jill M.Chief Operating OfficerMar 03, 2020 Buy$18.001,50027,000311,494Mar 03, 2020, 06:46 PM
Morris Richard StevenChief Financial OfficerMar 03, 2020 Buy$18.004007,200400Mar 03, 2020, 06:44 PM
Kapadia SandipDirectorMar 03, 2020 Buy$18.005,00090,0005,000Mar 03, 2020, 06:43 PM
Islam SaqibDirectorMar 03, 2020 Buy$18.005,00090,0005,000Mar 03, 2020, 06:41 PM
Goldsmith Bruce ACEO and PresidentMar 03, 2020 Buy$18.001,10019,8001,100Mar 03, 2020, 06:40 PM
Fotopoulos AlexandrosChief Technical OfficerMar 03, 2020 Buy$18.005,50099,0005,500Mar 03, 2020, 06:38 PM
Countouriotis AthenaDirectorMar 03, 2020 Buy$18.008,900160,2008,900Mar 03, 2020, 06:37 PM
Cale Edgar B.GC and Corporate SecretaryMar 03, 2020 Buy$18.002,00036,0002,000Mar 03, 2020, 06:35 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Kapadia SandipDirector12/01/20225,964
Fotopoulos AlexandrosChief Technical Officer11/22/20224,948
Toernsen Monika MariaChief Commercial Officer09/19/20222,539
ORBIMED ADVISORS LLC10% Owner05/04/2022588,790
ORBIMED ADVISORS LLC10% Owner05/03/2022427,495
ORBIMED ADVISORS LLC10% Owner01/20/2022254,000
Goldsmith Bruce ACEO and President03/21/202231,500
ORBIMED ADVISORS LLC10% Owner01/20/20222,000,522
ORBIMED ADVISORS LLC10% Owner01/19/2022221,263
ORBIMED ADVISORS LLC10% Owner01/18/2022626,262
ORBIMED ADVISORS LLC10% Owner01/14/202257,680
ORBIMED ADVISORS LLC10% Owner01/12/2022565,000
ORBIMED ADVISORS LLC10% Owner01/11/202245,346
ORBIMED ADVISORS LLC10% Owner01/13/2022230,736
Quigley Jill M.Chief Operating Officer12/08/202116,554
Romano GaryChief Medical Officer03/15/202180,700
Romano GaryChief Medical Officer03/15/2021211,013
Quigley Jill M.Chief Operating Officer01/20/202139,011
Quigley Jill M.Chief Operating Officer01/14/2021490,570
Countouriotis AthenaDirector03/24/2020149,750
Ratcliffe LiamDirector03/03/202050,400
Ratcliffe LiamDirector03/03/20209,900,000
ORBIMED ADVISORS LLC10% Owner02/28/20206,719,400
Versant Venture Capital VI, L.P.10% Owner03/03/20204,050,000
Frazier Life Sciences IX, L.P.10% Owner03/03/20209,900,000
Woiwode ThomasDirector03/03/20204,050,000
Heron Patrick JDirector03/03/20209,900,000
Yamada TadatakaDirector03/03/2020117,000
Ratcliffe LiamDirector03/03/202050,400
Quigley Jill M.Chief Operating Officer03/03/202018,000
Quigley Jill M.Chief Operating Officer03/03/202027,000
Morris Richard StevenChief Financial Officer03/03/20207,200
Kapadia SandipDirector03/03/202090,000
Islam SaqibDirector03/03/202090,000
Goldsmith Bruce ACEO and President03/03/202019,800
Fotopoulos AlexandrosChief Technical Officer03/03/202099,000
Countouriotis AthenaDirector03/03/2020160,200
Cale Edgar B.GC and Corporate Secretary03/03/202036,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2022
06/30/2022
0.09%
1Q
09/30/2022
03/31/2022
0.19%
2Q
09/30/2022
12/31/2021
1.94%
3Q
09/30/2022
09/30/2021
2.45%
4Q
09/30/2022
06/30/2021
3.35%
5Q
09/30/2022
03/31/2021
5.94%
6Q
09/30/2022
12/31/2020
40.82%
7Q
09/30/2022
09/30/2020
49.91%
8Q
Load More

Period of Report: 09/30/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2022
0.09%
1Q
03/31/2022
0.19%
2Q
12/31/2021
1.94%
3Q
09/30/2021
2.45%
4Q
06/30/2021
3.35%
5Q
03/31/2021
5.94%
6Q
12/31/2020
40.82%
7Q
09/30/2020
49.91%
8Q
Load More